{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:26:35Z","timestamp":1790785595587,"version":"4.1.0"},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,9,25]]},"DOI":"10.1253\/circj.cj-19-0421","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:02:51Z","timestamp":1565733771000},"page":"2010-2016","source":"Crossref","is-referenced-by-count":18,"title":["Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis"],"prefix":"10.1253","volume":"83","author":[{"given":"Kasumi","family":"Ishibuchi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"},{"name":"Department of Medicine II, Kansai Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Otsuji","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Takiuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Tamaru","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Nakabayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kusumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kakishita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shimatani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihiko","family":"Higashino","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Higashi Takarazuka Satoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? <i>N Engl J Med<\/i> 1984; 310: 819\u2013824."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. <i>J Am Coll Cardiol<\/i> 2007; 49: 839\u2013848.","DOI":"10.1016\/j.jacc.2006.10.055"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kawase Y, Matsuo H, Akasaka T, Shiono Y, Tanaka N, Amano T, et al. Clinical use of physiological lesion assessment using pressure guidewires: An expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics. <i>Cardiovasc Interv Ther<\/i> 2019; 34: 85\u201396.","DOI":"10.1007\/s12928-018-0559-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. <i>N Engl J Med<\/i> 2012; 367: 991\u20131001.","DOI":"10.1056\/NEJMoa1205361"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van\u2019t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. <i>N Engl J Med<\/i> 2009; 360: 213\u2013224.","DOI":"10.1056\/NEJMoa0807611"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tanaka N, Nakamura M, Akasaka T, Kadota K, Uemura S, Amano T, et al. One-year outcome of fractional flow reserve-based coronary intervention in Japanese daily practice: CVIT-DEFER registry. <i>Circ J<\/i> 2017; 81: 1301\u20131306.","DOI":"10.1253\/circj.CJ-16-1213"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. <i>Circulation<\/i> 1993; 87: 1354\u20131367.","DOI":"10.1161\/01.CIR.87.4.1354"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. <i>J Am Coll Cardiol<\/i> 2014; 64: 1929\u20131949.","DOI":"10.1016\/j.jacc.2014.07.017"},{"key":"9","unstructured":"9. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC\/EACTS guidelines on myocardial revascularization. <i>Rev Esp Cardiol (Engl Ed)<\/i> 2015; 68: 144."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Patel HR, Shah P, Bajaj S, Virk H, Bikkina M, Shamoon F. Intracoronary adenosine-induced ventricular arrhythmias during fractional flow reserve (FFR) measurement: Case series and literature review. <i>Cardiovasc Interv Ther<\/i> 2017; 32: 374\u2013380.","DOI":"10.1007\/s12928-016-0427-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lee JM, Kato D, Oi M, Toyofuku M, Takashima H, Waseda K, et al. Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: A patient-level pooled analysis. <i>EuroIntervention<\/i> 2016; 12: e208\u2013e215.","DOI":"10.4244\/EIJV12I2A34"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, et al. Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. <i>Heart Vessels<\/i> 2015; 30: 477\u2013483.","DOI":"10.1007\/s00380-014-0508-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tanaka N, Takahashi Y, Ishihara H, Kawakami T, Ono H. Usefulness and safety of intracoronary administration of nicorandil for evaluating fractional flow reserve in Japanese patients. <i>Clin Cardiol<\/i> 2015; 38: 20\u201324.","DOI":"10.1002\/clc.22344"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Seo MK, Koo BK, Kim JH, Shin DH, Yang HM, Park KW, et al. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement. <i>Circ Cardiovasc Intv<\/i> 2012; 5: 401\u2013405.","DOI":"10.1161\/CIRCINTERVENTIONS.111.965392"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takami H, Sonoda S, Muraoka Y, Sanuki Y, Kashiyama K, Fukuda S, et al. Impact ofadditional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5\u2019-triphosphate infusion. <i>J Cardiol<\/i> 2017; 69: 119\u2013124.","DOI":"10.1016\/j.jjcc.2016.01.018"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van\u2019t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. <i>J Am Coll Cardiol<\/i> 2007; 49: 2105\u20132111.","DOI":"10.1016\/j.jacc.2007.01.087"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. <i>N Engl J Med<\/i> 2017; 376: 1824\u20131834.","DOI":"10.1056\/NEJMoa1700445"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. G\u00f6tberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. <i>N Engl J Med<\/i> 2017; 376: 1813\u20131823.","DOI":"10.1056\/NEJMoa1616540"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML. Polymorphous ventricular tachycardia: A side effect of intracoronary papaverine. <i>J Am Coll Cardiol<\/i> 1990; 15: 275\u2013278.","DOI":"10.1016\/S0735-1097(10)80048-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Vrolix M, Piessens J, De Geest H. Torsades de pointes after intracoronary papaverine. <i>Eur Heart J<\/i> 1991; 12: 273\u2013276.","DOI":"10.1093\/oxfordjournals.eurheartj.a059880"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, et al. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. <i>Eur Heart J<\/i> 2013; 34: 2055\u20132062.","DOI":"10.1093\/eurheartj\/eht040"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oi M, Toyofuku M, Matsumura Y, Motohashi Y, Takahashi K, Kawase Y, et al. Utility of nicorandil for the measurement of coronary fractional flow reserve. <i>Cardiovasc Interv Ther<\/i> 2014; 29: 24\u201330.","DOI":"10.1007\/s12928-013-0207-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. <i>N Engl J Med<\/i> 2014; 371: 1208\u20131217.","DOI":"10.1056\/NEJMoa1408758"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Frydman AM, Chapelle P, Diekmann H, Bruno R, Thebault JJ, Bouthier J, et al. Pharmacokinetics of nicorandil. <i>Am J Cardiol<\/i> 1989; 63: 25J\u201333J.","DOI":"10.1016\/0002-9149(89)90201-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Toth GG, De Bruyne B, Rusinaru D, Di Gioia G, Bartunek J, Pellicano M, et al. Impact of right atrial pressure on fractional flow reserve measurements. <i>J Am Coll Cardiol Intv<\/i> 2016; 9: 453\u2013459.","DOI":"10.1016\/j.jcin.2015.11.021"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/10\/83_CJ-19-0421\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T03:26:42Z","timestamp":1569641202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/10\/83_CJ-19-0421\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0421","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]}}}